Psychiatr. pro Praxi, 2007; 8(5): 222-224

Quetiapine in the treatment of depressive episode BAD

prof. MUDr. Jaroslav Bouček CSc
Psychiatrická klinika FN a LF UP, Olomouc

There are characteresed the bipolar affective disorder inclusive bipolar I and II disorder and quetiapine as antipsychotic the second generation. There are writed the indications of quetiapine by schizophrenie, by acute mania etc. It was presented BOLDER trial, where quetiapine has proved effectivity in the treatment of depressive episode BAD.

Keywords: mania and depressive episode of BAD, quetiapin, indication of quetiapin

Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bouček J. Quetiapine in the treatment of depressive episode BAD. Psychiatr. praxi. 2007;8(5):222-224.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol. 1995; 30: 279-292. Go to original source... Go to PubMed...
    2. Bouček J, a kol. Speciální psychiatrie LF UP Olomouc, 2006, s. 244.
    3. Calabrese JR, Keck PE, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351-1360. Go to original source... Go to PubMed...
    4. Grof P, Tůma I. Bipolární stabilizátory nálady: Jaký, pro koho, kdy a jak dlouho? Psychiatrie; 2004 8 (4): 315-320.
    5. Jones M, Huizar K. Quetiapine monotherapy for mania asssociated with bipolar disorder. International Journal of Psychiatry in Clinical Practice 2003; 7 (4): 310-311, Abs P14.
    6. Keating GM, Robinson DM. Quetiapine. A review of its use in the treatment of bipolar depression. Drugs 2007; 67 (7): 1077-1095. Go to original source... Go to PubMed...
    7. Masopust J, Urban A, Vališ M. Jaká je budoucnost quetiapinu? Psychiat. pro praxi, 2006; (1): 43-49.
    8. Mohr P, Votava M. Quetiapin. Farmakoterapie; 2005 (6): 583-588.
    9. Náhunek K, a spol. Klozapin v léčbě depresivní fáze maniodepresivní psychózy. Act. Nerv. Superior, 1973.
    10. Paulsson B, Huizar K. Quetiapine monotherapy for the treatment of mania in bipolar disorder. A randomised controlled trial. European Psychiatry (Paris) 2004; 19 (Suppl 1): 2075, Abs P30.
    11. Seifertová D. Quetiapin v léčbě manické fáze bipolární afektivní poruchy. Psychiatrie, 2004; 8 (3): 202-204.
    12. Seifertová D, Praško J, Höschl C. Postupy v léčbě psychických poruch. Academia Medica Pragensis, 2004, s. 472.
    13. Smolík P. Duševní a behaviorální poruchy, Maxdorf, 1996, 2002.
    14. Stopková P, Novák T, Růžičková M, Fridrichová H, Höschl C. Registr pacientů s bipolární afektivní poruchou. Supplementum 1, 2006, Psychiatrie 10.
    15. Švestka J. Nová psychofarmaka: antipsychotikum quetiapin. Psychiatrie, 2000; 2: 120-133.
    16. Švestka J. Olanzapin v léčbě afektivních poruch. Psychiatrie, 2003; 7 (3): 194-202.
    17. Vzdělávací program WPA/ STD - depresivní poruchy. Přehled a základní aspekty 1997, Eli Lilly ČR.
    18. Zhong K, Tariot P, Minkwitz MC, Devine NA, Mintzer J. Quetiapine for the treatment of agitation in elderly institutionalized patients with dementia: a randomized, double-blind trial. In: 18th Annual Meeting of the American Association for Geriatric Psychiatry, San Diego, CA, USA, 3-6 March, 2005.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.